Prestige (PBH) Director John E. Byom Receives RSU Award

What Happened
John E. Byom, a director of Prestige Consumer Healthcare (PBH), was granted 2,981 restricted stock units (RSUs) on August 4, 2026. The filing shows an acquisition price of $0.00 (award), and the award was valued at $155,000 using the closing share price of $52.00 on August 4, 2026. The RSUs convert to one share of common stock per vested unit when settled.

Key Details

• Transaction date: 2026-08-04 (Form 4 filed 2026-08-05).
• Grant: 2,981 RSUs; reported acquisition price $0.00; valuation based on $52.00 closing price → total ≈ $155,000.
• Vesting/settlement: RSUs vest on the first anniversary of the grant and will be settled by delivery of one share per vested RSU promptly following the earliest of (1) the reporting person’s death, (2) separation, or (3) a change in control (per footnote).
• Shares owned after transaction: not specified in the provided filing.
• Timeliness: Filing appears timely (filed one day after the grant).

Context
This was an award under the issuer’s director compensation program (compensation, not an open-market purchase). RSUs are a form of deferred equity compensation and do not represent an immediate cash purchase or sale; they only convert to shares upon vesting/settlement and therefore do not alone signal immediate insider buying or selling.